Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival

 

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines(PubMed)

 

Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas

 

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism

 

Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target

 

Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents

 

Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect

 

Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme